Royal Bank Of Canada Sage Therapeutics, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 19,048 shares of SAGE stock, worth $105,716. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,048

Previous 22,099 13.81%

Holding current value

$105,716

Previous $239,000 42.68%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.02 - $13.08 $21,418 - $39,907	-3,051 Reduced 13.81%	19,048 $137,000
Q2 2024 Aug 14, 2024	BUY	$10.58 - $17.9 $45,197 - $76,468	4,272 Added 23.96%	22,099 $239,000
Q1 2024 Nov 05, 2024	SELL	$18.62 - $26.95 $79,544 - $115,130	-4,272 Reduced 19.33%	17,827 $334,000
Q1 2024 May 15, 2024	SELL	$18.62 - $26.95 $254,107 - $367,786	-13,647 Reduced 43.36%	17,827 $334,000
Q4 2023 Feb 14, 2024	SELL	$17.1 - $22.26 $105,096 - $136,809	-6,146 Reduced 16.34%	31,474 $682,000
Q3 2023 Nov 14, 2023	BUY	$16.75 - $48.98 $365,954 - $1.07 Million	21,848 Added 138.52%	37,620 $774,000
Q2 2023 Aug 14, 2023	BUY	$40.65 - $59.54 $37,316 - $54,657	918 Added 6.18%	15,772 $741,000
Q1 2023 May 15, 2023	SELL	$37.27 - $46.57 $108,343 - $135,378	-2,907 Reduced 16.37%	14,854 $623,000
Q4 2022 Feb 14, 2023	BUY	$32.2 - $43.61 $221,664 - $300,211	6,884 Added 63.29%	17,761 $677,000
Q3 2022 Nov 14, 2022	SELL	$32.28 - $43.27 $149,133 - $199,907	-4,620 Reduced 29.81%	10,877 $426,000
Q2 2022 Aug 15, 2022	SELL	$27.52 - $37.99 $107,905 - $148,958	-3,921 Reduced 20.19%	15,497 $500,000
Q1 2022 May 16, 2022	SELL	$30.71 - $45.71 $258,455 - $384,695	-8,416 Reduced 30.24%	19,418 $643,000
Q4 2021 Feb 14, 2022	BUY	$37.06 - $47.11 $212,353 - $269,940	5,730 Added 25.92%	27,834 $1.18 Million
Q3 2021 Nov 15, 2021	SELL	$40.26 - $57.37 $1.95 Million - $2.77 Million	-48,342 Reduced 68.62%	22,104 $979,000
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $3.87 Million - $5.59 Million	70,446 New	70,446 $4 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $330M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Sage Therapeutics, Inc. Transaction History